JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1994) 12, 25-37    DOI: 10.1677/jme.0.0120025
© 1994 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duguay, S J
Right arrow Articles by Dickhoff, W W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duguay, S J
Right arrow Articles by Dickhoff, W W

Differential expression and hormonal regulation of alternatively spliced IGF-I mRNA transcripts in salmon

S J Duguay, P Swanson and W W Dickhoff

Salmon have been shown to express alternatively spliced IGF-I mRNA transcripts coding for four different IGF-I prohormones. These transcripts, now designated Ea-1, Ea-2, Ea-3 and Ea-4, differ in size due to the inclusion of additional sequences in the E domain-coding region of the molecule. In this study, the tissue distribution and hormonal regulation of expression of alternatively spliced IGF-I mRNA transcripts were investigated in coho salmon. IGF-I mRNAs were detected by solution hybridization/RNase protection assay in all tissues examined. GH treatment significantly increased hepatic IGF-I mRNA content. Hepatic IGF-I mRNA levels were not influenced by prolactin or somatolactin. Heart, fat, brain, kidney, spleen and ovary IGF-I mRNA levels were not affected by GH, prolactin or somatolactin. Ea-1, Ea-3 and Ea-4 mRNA transcripts were detectable in the liver, and Ea-1 and Ea-3 levels increased dramatically in response to GH treatment, whereas the amount of Ea-4 mRNA was unchanged. Most non-hepatic tissues expressed only the Ea-4 transcript, and expression was not influenced by GH, prolactin or somatolactin. Ea-1 and Ea-3 transcripts were visible in gill samples from fish treated with GH. The ovaries of juvenile fish expressed Ea-1, Ea-2 and Ea-4. The amounts of these transcripts were not changed by gonadotrophin treatment. During smoltification of juvenile coho salmon, liver and gill IGF-I mRNA levels increased with increasing plasma GH and thyroxine concentrations. Muscle, brain and ovary IGF-I mRNA levels were unchanged during this period.

These data suggest that the liver is a major site of IGF-I production in response to GH. Heart, fat, brain, kidney, spleen and ovary did not show increased IGF-I mRNA levels in response to GH treatment. GH and prolactin had inconsistent effects on muscle IGF-I mRNA levels. Somatolactin and a gonadotrophin preparation did not stimulate IGF-I expression in tissues of juvenile fish. Differences in tissue GH responsiveness can be partially explained by the expression of alternatively spliced IGF-I mRNAs. Of the four hepatic IGF-I mRNA transcripts, Ea-1 and Ea-3 are GH-responsive, while Ea-2 and Ea-4 are not. Most non-hepatic tissues express only the Ea-4 transcript, and IGF-I mRNA levels do not increase after GH treatment. The increased IGF-I mRNA levels observed in gill tissue during smoltification suggest that other factors, in addition to GH, may regulate IGF-I expression. These data are also consistent with the hypothesis that IGF-I may mediate the osmoregulatory functions of GH during sea water adaptation.




This article has been cited by other articles:


Home page
EndocrinologyHome page
T. Maures, S. J. Chan, B. Xu, H. Sun, J. Ding, and C. Duan
Structural, Biochemical, and Expression Analysis of Two Distinct Insulin-Like Growth Factor I Receptors and Their Ligands in Zebrafish
Endocrinology, May 1, 2002; 143(5): 1858 - 1871.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. J. Smith, E. L. Spurrell, J. Coakley, C. J. Hinds, R. J. M. Ross, A. R. Krainer, and S. L. Chew
An Exonic Splicing Enhancer in Human IGF-I Pre-mRNA Mediates Recognition of Alternative Exon 5 by the Serine-Arginine Protein Splicing Factor-2/ Alternative Splicing Factor
Endocrinology, January 1, 2002; 143(1): 146 - 154.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
V. Perrot, E. B. Moiseeva, Y. Gozes, S. J. Chan, and B. Funkenstein
Insulin-Like Growth Factor Receptors and Their Ligands in Gonads of a Hermaphroditic Species, the Gilthead Seabream (Sparus aurata): Expression and Cellular Localization
Biol Reprod, July 1, 2000; 63(1): 229 - 241.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
C. Duan
Nutritional and Developmental Regulation of Insulin-like Growth Factors in Fish
J. Nutr., February 1, 1998; 128(2): 306 - 306.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Reinecke, A. Schmid, R. Ermatinger, and D. Loffing-Cueni
Insulin-Like Growth Factor I in the Teleost Oreochromis mossambicus, the Tilapia: Gene Sequence, Tissue Expression, and Cellular Localization
Endocrinology, September 1, 1997; 138(9): 3613 - 3619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. P. Kulik, V. M. Kavsan, F. M. A. van Schaik, L. A. Nolten, P. H. Steenbergh, and J. S. Sussenbach
The Promoter of the Salmon Insulin-like Growth Factor I Gene Is Activated by Hepatocyte Nuclear Factor 1
J. Biol. Chem., January 20, 1995; 270(3): 1068 - 1073.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society for Endocrinology.